Salwa S Zghebi

Has grant

The University of Manchester
Country flagUnited Kingdom

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

(Co-PI) Are artificial intelligence (AI) enabled diagnostic tools for mental health widening health inequalities for people with MLTC: A mixed-methods study

Open Date: 2025-01-01

Close Date: 2026-06-01

Grant: Close

(co-PI) Ethnic inequalities in multimorbidity burden and their relationship to clinical outcomes in people with diabetes in Greater Manchester

Open Date: 2024-08-01

Close Date: 2025-07-01

Grant: Close

(Co-I) Trends in incidence and mortality of pancreatic cancer and risk prediction from primary care records in England

Open Date: 2023-08-01

Close Date: 2024-07-01

Grant: Close

Development and validation of a risk stratification tool for patients with acute myocardial infarction (AMI) in UK primary care

Open Date: 2020-05-01

Close Date: 2022-04-01

Grant: Close

Identifying trends and causes of hospitalisations in people with and without the top 5 chronic conditions: a population-based study

Open Date: 2020-05-01

Close Date: 2023-04-01

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Background and aims Assessment of mortality trends and real-world outcomes are important for monitoring acute myocardial infarction (AMI) care, although there is limited data beyond 1-year post incident AMI. Methods We used Clinical Practice Research Datalink Aurum to identify patients ≥ 35 with incident AMI between 1 Jan 2006 to 31 Dec 2014. Data was also extracted from three other sources. Risk of all-cause and cardiovascular (CV)-related mortality, incident heart failure (HF), recurrent AMI, and cerebrovascular accidents (CVA) were calculated at 1- and 5-years using regression analysis—2006 was the comparator. Results We identified 94,241 patients with AMI. The 1-year risk for multiple outcomes fell by 2014, including all-cause mortality (hazard ratio (HR): 0.82, 95% CI: 0.75-0.90), CV-related mortality (HR: 0.69, 95% CI: 0.60-0.78), and recurrent AMI (HR 0.72, 95% CI: 0.66-0.79). The 1-year risk for incident HF increased (HR: 1.18, 95% CI: 1.08-1.28) whilst CVA risk did not change (HR: 1.11, 95% CI: 0.98-1.26). At 5-years, the risk fell for all-cause mortality (HR: 0.82, 95% CI: 0.79-0.87), CV-related mortality (HR: 0.68, 95% CI: 0.62-0.74), and recurrent AMI (HR: 0.71, 95% CI: 0.65-0.75) by 2014. The 5-year risk for incident HF increased (HR: 1.15, 95% CI: 1.08-1.23), whilst CVA risk also increased significantly (HR: 1.16, 95% CI: 1.07-1.26) by 2014. Conclusions Across 2006-2014, we observed a falling risk of all-cause mortality, CV-related mortality, and recurrent AMI at 1- and 5-years post incident AMI. Countervailing trends were seen for incident HF, where the risk for CVA also increased significantly by 5-years. Graphical Abstract

Year:

2026

Year:

2026

Acute lymphocytic leukemia (ALL) is a hematologic malignancy commonly treated with pegasparaginase (PEG-ASP). Limited data exist on PEG-ASP-induced hepatotoxicity in the Saudi population; therefore, this study aimed to determine the rate and risk factors of PEG-ASP-induced hepatotoxicity in Saudi pediatric and adult ALL patients. This retrospective cohort study reviewed the records of ALL patients who had been treated with or received at least 1 dose of PEG-ASP between 2014 and 2021. Hepatotoxicity was graded using the Common Terminology Criteria for Adverse Events (CTCAE) Version 5. Bivariate and multiple logistic regression analyses were used to analyze the relationships between the variables and the risk of PEG-ASP-induced hepatotoxicity. A total of 368 patients were included in the study, with an overall hepatotoxicity rate of 38.8 (95% CI = 33.9–43.8) per 100 patients. Hepatotoxicity was observed in 35.7% (n = 117/328) of pediatric patients and 7.6% (n = 25/328) of adult patients. Risk factors of hepatotoxicity were identified: bilirubin level (odds ratio = 1.324, 95% CI = 1.089–1.610), presence of hyperdiploidy (OR = 1.456, 95% CI = 1.112–1.907), PEG-ASP dose (OR = 1.287, 95% CI = 1.021–1.623), and vincristine administration (OR = 1.398, 95% CI = 1.087–1.798). Additionally, the liver function test levels included alanine aminotransferase (OR = 1.512, 95% CI = 1.198–1.909), aspartate aminotransferase (OR = 1.445, 95% CI = 1.156–1.806), and gamma-glutamyl transferase (OR = 1.367, 95% CI = 1.089–1.716). PEG-ASP-induced hepatotoxicity poses a significant risk to Saudi patients with ALL. Further studies are needed to identify additional risk factors and improve the management of hepatotoxicity in ALL patients receiving PEG-ASP.

Year:

2026

Background Multiple long-term conditions (MLTC) - which refer to the coexistence in an individual of two or more long-term conditions - are a growing global concern, causing significant strain on healthcare systems and increasing care costs. Research into MLTC is a strategic priority for healthcare services, policymakers and research funders. Methods To address these complexities, the UK’s National Institute for Health and Care Research (NIHR) established the MLTC Cross-NIHR Collaboration (MLTC CNC) programme, to foster interdisciplinary collaboration and address key gaps in MLTC research. As part of this initiative, the Methodologies Workstream organised a two-day stakeholder workshop in March 2024 aimed at identifying current methodological challenges in MLTC research, prioritising key areas for improvement, and developing strategies to enhance research methodologies. The workshop employed a participatory and iterative approach, using structured presentations, facilitated group work, and the Nominal Group Technique (NGT) to promote cross-disciplinary collaboration and achieve consensus on key research priorities for MLTC. Results Twenty-three delegates attended the workshop from a range of institutions and sectors, including representatives from data science, epidemiology, clinical trials, quality improvement, social sciences, healthcare management, clinical practice, industry, patient advocacy groups, policymakers, patients, carers, and public representatives. The workshop identified critical knowledge gaps in MLTC research methodologies, including challenges with disease classification, data integration, analytical approaches, and the inclusion of diverse population subgroups. Conclusion By addressing these methodological gaps and fostering collaboration across disciplines, the MLTC research community can generate more rigorous, inclusive, and impactful evidence, ultimately improving healthcare delivery and patient outcomes.

Year:

2025

Background Burnout is associated with career disengagement among general practitioners (GPs), but the underlying mechanisms of this association remain poorly understood. Objective This study examined the pathways linking burnout to career disengagement factors among GPs. Methods An 11-item online questionnaire, including validated abbreviated measures of burnout outcomes (single items on emotional exhaustion (EE) and depersonalisation), career disengagement factors (intention to quit patient care, work–life balance, presenteeism and job satisfaction), and demographic information, was distributed to a random sample of GPs in England between December 2019 and April 2020. Correlations between burnout outcomes and disengagement factors were assessed, followed by a path analysis using a generalized structural equation model, to examine directional relationships between burnout outcomes and survey variables. Results A total of 351 GPs from 57 different medical practices completed the questionnaire. Up to one in four GPs (22.5%) experienced emotional exhaustion, while up to one in three (27.4%) experienced depersonalisation on a weekly basis. In addition, one in three GPs (33.3%) expressed a moderate-to-high intention to quit patient care within the next 5 years. Moreover, one in five GPs (18.8%) reported job dissatisfaction, two in five GPs (40.7%) indicated poor work–life balance, and up to one in two GPs (27.4%) reported presenteeism in the past year. In the path analysis, intention to quit patient care had significant direct associations with both job satisfaction and burnout and significant indirect associations (via burnout) with work–life balance and presenteeism. GP demographics were excluded from the path analysis because they exhibited very weak correlations with dimensions of burnout and work engagement factors. Conclusion These findings highlight the urgent need for interventions and policies aimed at addressing burnout and improving job satisfaction to retain GPs. In addition, improving work–life balance and reducing presenteeism could serve as effective early preventative measures to reduce burnout and job dissatisfaction and, in turn, retain GPs.

Year:

2025

Year:

2025

Background Telemedicine has revolutionized the management of type 2 diabetes mellitus (T2DM) in primary care by improving access to health care services and enhancing health outcomes. Despite these advancements, it remains unclear whether telemedicine has reduced access inequalities among different demographic and socioeconomic groups. Objective This study aimed to investigate the most important demographic and socioeconomic factors associated with telemedicine use among individuals with T2DM in primary care. Methods We conducted a systematic review and meta-analysis. Databases including MEDLINE, Embase, PsycINFO, Google Scholar, Scopus, and CINAHL were searched from inception to December 2023. The reference lists of eligible studies and other relevant systematic reviews were also searched. We included observational and cohort studies that assessed the effects of telemedicine interventions on individuals with T2DM in primary care. The core outcomes were the factors associated with telemedicine use, reported as adjusted odds ratios and 95% CIs for each factor, using a random-effects model. Heterogeneity was quantified using the I ² statistic, and publication bias was assessed. The protocol for this review was registered with PROSPERO (CRD42024550410). Results Of the 3006 records identified, 16 studies involving 71,336 patients were included in the meta-analysis. Female patients had higher odds of using telemedicine than males (pooled adjusted odds ratio [OR] 1.05, 95% CI 1.02-1.09). Older patients were significantly less likely to use telemedicine than younger patients (pooled OR 0.979, 95% CI 0.98-0.98). Compared with White patients, Black patients were less likely to use telemedicine (pooled OR 0.55, 95% CI 0.32-0.94), while no statistically significant differences were observed for Hispanic (pooled OR 1.075, 95% CI 0.36-3.24) or Asian participants (pooled OR 0.56, 95% CI 0.29-1.06). Patients with higher education levels had greater odds of using telemedicine than those with lower education levels (pooled OR 1.681, 95% CI 1.48-1.91). Conclusions This systematic review and meta-analysis provide evidence of significant disparities in telemedicine use among men, older adults, Black individuals, and those with lower levels of education who have T2DM in primary care. Given that these groups are among the most vulnerable to T2DM, these disparities highlight the critical need for strategic interventions and robust policies that ensure telemedicine fosters equitable access to health care while preventing further exacerbation of existing health inequalities.

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (28)

Hajira Dambha-Miller

Associate Professor in AI and Primary Care

University of Southampton

UNITED KINGDOM
View details

Rachel Ann Elliott

The University of Manchester

UNITED KINGDOM
View details

Rosa Parisi

Dean's Prize Research Fellow

The University of Manchester

UNITED KINGDOM
View details

Brian McMillan

The University of Manchester

UNITED KINGDOM
View details

Colin McCowan

University of St. Andrews

UNITED KINGDOM
View details

Darren Ashcroft

Professor

The University of Manchester

UNITED KINGDOM
View details

Antonia Marsden

The University of Manchester

UNITED KINGDOM
View details

Lamiece Hassan

The University of Manchester

UNITED KINGDOM
View details

Rupert Payne

Professor of Primary Care and Clinical Pharmacology

University of Exeter

UNITED KINGDOM
View details

Carolyn A. Chew‐Graham

-

UNITED KINGDOM
View details

Li-Chia Chen

The University of Manchester

UNITED KINGDOM
View details

Charlotte Morris

The University of Manchester

UNITED KINGDOM
View details

Evangelos Kontopantelis

The University of Manchester

UNITED KINGDOM
View details

Sarah Cotterill

The University of Manchester

UNITED KINGDOM
View details

Martin Rutter

Professor of Cardiometabolic Medicine

The University of Manchester

UNITED KINGDOM
View details

Simon de Lusignan

University of Oxford

UNITED KINGDOM
View details

Luke Paterson

University of Oxford

UNITED KINGDOM
View details

Ge Yu

Senior Lecturer in Health Economics and Econometrics

King’s College London

UNITED KINGDOM
View details

Muhammad Rashid

Senior Clinical Lecturer

Keele University

UNITED KINGDOM
View details

Benjamin Brown

Clinical Senior Lecturer

The University of Manchester

UNITED KINGDOM
View details

Glen Martin

Senior Lecturer in Health Data Science

The University of Manchester

UNITED KINGDOM
View details

Aneez Esmail

The University of Manchester

UNITED KINGDOM
View details

Maria Panagioti

The University of Manchester

UNITED KINGDOM
View details

Sarah Hughes

Senior Research Fellow

University of Birmingham

UNITED KINGDOM
View details

Victoria Keevil

Senior Clinical Lecturer and NIHR Exeter BRC Mid-Career Fellow

University of Exeter

UNITED KINGDOM
View details

Paul Little

University of Southampton

UNITED KINGDOM
View details

Azfar Ghaus Zaman

Clinical Professor of Cardiology

Frimley Health NHS Foundation Trust

UNITED KINGDOM
View details

Glenn Simpson

Senior Research Fellow

University of Southampton

UNITED KINGDOM
View details